Lymphocyte activation during acute simian/human immunodeficiency virus SHIV(89.6PD) infection in macaques. 1999

M Wallace, and P M Waterman, and J L Mitchen, and M Djavani, and C Brown, and P Trivedi, and D Horejsh, and M Dykhuizen, and M Kitabwalla, and C D Pauza
Department of Pathology, University of Wisconsin, Madison, Wisconsin 53705-1532, USA.

Host-virus interactions control disease progression in human immunodeficiency virus-infected human beings and in nonhuman primates infected with simian or simian/human immunodeficiency viruses (SHIV). These interactions evolve rapidly during acute infection and are key to the mechanisms of viral persistence and AIDS. SHIV(89.6PD) infection in rhesus macaques can deplete CD4(+) T cells from the peripheral blood, spleen, and lymph nodes within 2 weeks after exposure and is a model for virulent, acute infection. Lymphocytes isolated from blood and tissues during the interval of acute SHIV(89.6PD) infection have lost the capacity to proliferate in response to phytohemagglutinin (PHA). T-cell unresponsiveness to mitogen occurred within 1 week after mucosal inoculation yet prior to massive CD4(+) T-cell depletion and extensive virus dissemination. The lack of mitogen response was due to apoptosis in vitro, and increased activation marker expression on circulating T cells in vivo coincided with the appearance of PHA-induced apoptosis in vitro. Inappropriately high immune stimulation associated with rapid loss of mature CD4(+) T cells suggested that activation-induced cell death is a mechanism for helper T-cell depletion in the brief period before widespread virus dissemination. Elevated levels of lymphocyte activation likely enhance SHIV(89.6PD) replication, thus increasing the loss of CD4(+) T cells and diminishing the levels of virus-specific immunity that remain after acute infection. The level of surviving immunity may dictate the capacity to control virus replication and disease progression. We describe this level of immune competence as the host set point to show its pivotal role in AIDS pathogenesis.

UI MeSH Term Description Entries
D008212 Lymphocyte Depletion Immunosuppression by reduction of circulating lymphocytes or by T-cell depletion of bone marrow. The former may be accomplished in vivo by thoracic duct drainage or administration of antilymphocyte serum. The latter is performed ex vivo on bone marrow before its transplantation. Depletion, Lymphocyte
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008253 Macaca mulatta A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. Chinese Rhesus Macaques,Macaca mulatta lasiota,Monkey, Rhesus,Rhesus Monkey,Rhesus Macaque,Chinese Rhesus Macaque,Macaca mulatta lasiotas,Macaque, Rhesus,Rhesus Macaque, Chinese,Rhesus Macaques,Rhesus Macaques, Chinese,Rhesus Monkeys
D008934 Mitogens Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed) Mitogen,Phytomitogen,Phytomitogens
D010835 Phytohemagglutinins Mucoproteins isolated from the kidney bean (Phaseolus vulgaris); some of them are mitogenic to lymphocytes, others agglutinate all or certain types of erythrocytes or lymphocytes. They are used mainly in the study of immune mechanisms and in cell culture. Kidney Bean Lectin,Kidney Bean Lectins,Lectins, Kidney Bean,Phaseolus vulgaris Lectin,Phaseolus vulgaris Lectins,Phytohemagglutinin,Hemagglutinins, Plant,Lectin, Kidney Bean,Lectin, Phaseolus vulgaris,Lectins, Phaseolus vulgaris,Plant Hemagglutinins
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015302 Simian Immunodeficiency Virus Species of the genus LENTIVIRUS, subgenus primate immunodeficiency viruses (IMMUNODEFICIENCY VIRUSES, PRIMATE), that induces acquired immunodeficiency syndrome in monkeys and apes (SAIDS). The genetic organization of SIV is virtually identical to HIV. SIV (Simian immunodeficiency virus),Immunodeficiency Viruses, Simian,Simian Immunodeficiency Viruses,Immunodeficiency Virus, Simian
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte

Related Publications

M Wallace, and P M Waterman, and J L Mitchen, and M Djavani, and C Brown, and P Trivedi, and D Horejsh, and M Dykhuizen, and M Kitabwalla, and C D Pauza
September 2000, Virology,
M Wallace, and P M Waterman, and J L Mitchen, and M Djavani, and C Brown, and P Trivedi, and D Horejsh, and M Dykhuizen, and M Kitabwalla, and C D Pauza
February 2007, The Journal of general virology,
M Wallace, and P M Waterman, and J L Mitchen, and M Djavani, and C Brown, and P Trivedi, and D Horejsh, and M Dykhuizen, and M Kitabwalla, and C D Pauza
May 2018, Journal of virology,
M Wallace, and P M Waterman, and J L Mitchen, and M Djavani, and C Brown, and P Trivedi, and D Horejsh, and M Dykhuizen, and M Kitabwalla, and C D Pauza
May 1999, Journal of virology,
M Wallace, and P M Waterman, and J L Mitchen, and M Djavani, and C Brown, and P Trivedi, and D Horejsh, and M Dykhuizen, and M Kitabwalla, and C D Pauza
June 2002, Journal of acquired immune deficiency syndromes (1999),
M Wallace, and P M Waterman, and J L Mitchen, and M Djavani, and C Brown, and P Trivedi, and D Horejsh, and M Dykhuizen, and M Kitabwalla, and C D Pauza
August 2003, Journal of virology,
M Wallace, and P M Waterman, and J L Mitchen, and M Djavani, and C Brown, and P Trivedi, and D Horejsh, and M Dykhuizen, and M Kitabwalla, and C D Pauza
January 2009, Journal of virology,
M Wallace, and P M Waterman, and J L Mitchen, and M Djavani, and C Brown, and P Trivedi, and D Horejsh, and M Dykhuizen, and M Kitabwalla, and C D Pauza
April 2008, AIDS research and human retroviruses,
M Wallace, and P M Waterman, and J L Mitchen, and M Djavani, and C Brown, and P Trivedi, and D Horejsh, and M Dykhuizen, and M Kitabwalla, and C D Pauza
November 2007, Proceedings of the National Academy of Sciences of the United States of America,
M Wallace, and P M Waterman, and J L Mitchen, and M Djavani, and C Brown, and P Trivedi, and D Horejsh, and M Dykhuizen, and M Kitabwalla, and C D Pauza
November 2000, Journal of virology,
Copied contents to your clipboard!